135 related articles for article (PubMed ID: 14619639)
1. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
Schorge JO; Lea JS; Ashfaq R
J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
[TBL] [Abstract][Full Text] [Related]
2. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
[TBL] [Abstract][Full Text] [Related]
3. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
5. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
6. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
11. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
Lea JS; Shin CH; Sheets EE; Coleman RL; Gehrig PA; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Oct; 87(1):129-32. PubMed ID: 12468353
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in situ of the uterine cervix: management and outcome.
Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
[TBL] [Abstract][Full Text] [Related]
13. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
Dedecker F; Graesslin O; Bonneau S; Quéreux C
Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
[TBL] [Abstract][Full Text] [Related]
14. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
15. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
Im DD; Duska LR; Rosenshein NB
Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with positive margins after cervical conization.
Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
18. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
[TBL] [Abstract][Full Text] [Related]
19. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ.
Kennedy AW; elTabbakh GH; Biscotti CV; Wirth S
Gynecol Oncol; 1995 Aug; 58(2):274-7. PubMed ID: 7622120
[TBL] [Abstract][Full Text] [Related]
20. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
Tay EH; Yew WS; Ho TH
Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
